When can intravenous iron be initiated in a 30‑week pregnant woman admitted with influenza A, tachycardia 130 bpm, receiving intravenous fluids and undergoing non‑stress testing?

Timing of IV Iron in a 30-Week Pregnant Patient with Influenza A and Tachycardia

Defer IV iron administration until the acute influenza infection has resolved and the patient is hemodynamically stable, typically 7–14 days after symptom onset.

Rationale for Delaying IV Iron

Active infection is a relative contraindication to IV iron therapy. The 2024 American Journal of Hematology expert consensus explicitly recommends using IV iron "with caution in patients with acute or chronic infection" and states that treatment should be "stopped in patients with bacteremia." 1 Although influenza is viral rather than bacterial, the principle of avoiding supplemental iron during active infection applies because iron can theoretically facilitate pathogen growth and worsen inflammatory responses. 2

Specific Concerns in This Clinical Scenario

• Tachycardia to 130 bpm suggests ongoing systemic stress from influenza, and the patient requires hemodynamic stabilization with IV fluids before introducing additional interventions. 1

• Acute inflammatory state: Influenza A causes marked elevation of inflammatory markers. Research demonstrates that during febrile illness such as influenza, serum ferritin rises significantly and can take more than a month to normalize, making iron parameter interpretation unreliable. 3 Additionally, serum iron and transferrin saturation fall below normal range during the symptomatic stage of infection, even without true iron deficiency. 3

• Hypoferremia of inflammation: A study of H1N1 patients found that 92.9% had hypoferremia upon admission, which improved significantly 4 days after illness onset. 4 This transient hypoferremia reflects acute-phase redistribution rather than true iron deficiency requiring immediate repletion.

Pregnancy-Specific Safety Considerations

IV iron is acceptable after 13 weeks gestation but should be reserved for appropriate clinical indications. 1, 5 At 30 weeks, this patient is well into the third trimester, so gestational age is not a barrier. However:

• Fetal monitoring during or after IV iron is not required and not recommended. 1, 5

• Hypersensitivity reactions, though rare, can cause fetal bradycardia, particularly in the second and third trimesters. 6 Administering IV iron during acute illness when the patient is already tachycardic and hemodynamically stressed increases the risk of misattributing any adverse reaction.

Recommended Clinical Algorithm

Step 1: Stabilize the Acute Illness (Days 0–7)

• Continue IV fluids and supportive care for influenza A. 1
• Perform NST as planned to assess fetal well-being. 1
• Monitor vital signs including pulse, blood pressure, respiratory rate, temperature, and oxygen saturation at least twice daily. 1
• Assess for volume depletion and cardiac complications, which influenza can exacerbate. 1

Step 2: Reassess After Acute Phase (Days 7–14)

• Wait until the patient is afebrile for at least 48–72 hours and tachycardia has resolved (heart rate <100 bpm at rest). 1
• Confirm absence of secondary bacterial infection (e.g., pneumonia, which complicates influenza in up to 25% of hospitalized cases and would further delay IV iron). 7
• Recheck hemoglobin and iron parameters only after inflammatory markers normalize, as earlier testing yields falsely elevated ferritin and falsely low serum iron. 3

Step 3: Administer IV Iron if Indicated (After Day 14)

• Confirm true iron deficiency: ferritin <30 ng/mL (or <100 ng/mL with transferrin saturation <20%). 1, 5
• Use a single total-dose infusion formulation (ferumoxytol, low-molecular-weight iron dextran, or ferric derisomaltose) rather than ferric carboxymaltose, which causes hypophosphatemia in 58% of patients. 1, 2
• Administer in a monitored setting with resuscitation equipment available, observing for 30 minutes post-infusion. 1

Common Pitfalls to Avoid

• Do not check iron parameters within 4 weeks of any IV iron dose, as circulating iron interferes with assays and ferritin remains falsely elevated. 8, 5

• Do not assume anemia during acute infection represents iron deficiency. Influenza causes transient hypoferremia (92.9% of H1N1 patients) that resolves spontaneously within 4–7 days. 4, 3

• Do not administer IV iron if hemoglobin >15 g/dL or if active infection persists. 1, 2

• Avoid ferric carboxymaltose in pregnancy if repeat dosing may be needed, as it causes hypophosphatemia in 58% of cases versus 4% with ferric derisomaltose. 1, 2

Alternative: Oral Iron During Recovery

If hemoglobin is >10 g/dL and the patient can tolerate oral intake, initiate oral ferrous sulfate 60–120 mg elemental iron daily between meals during the recovery phase (Days 7–14). 5 Reassess hemoglobin after 4 weeks, expecting an increase of ≥1 g/dL. 5 Reserve IV iron for failure of oral therapy, hemoglobin <10 g/dL, or gastrointestinal intolerance. 5